Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Neurology
|
October 15, 2003
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome
E J Pappert, C G Goetz, E D Louis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 1997
Progressive cognitive decline with truncal/limb ataxia and ballistic movements
K Kompoliti, E J Pappert, C G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 26, 1999
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
E J Pappert, C G Goetz, F G Niederman, et al.
Clinical Neuropharmacology
|
October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's disease
N J Diederich, C G Goetz, R Raman, et al.
European Journal of Pharmacology
|
July 3, 1998
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes
E J Pappert, C G Goetz, G T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1996
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use
E J Pappert, C Buhrfiend, J W Lipton, et al.
Neurology
|
August 1, 1994
Inclusion body myositis: treatment with intravenous immunoglobulin
A A Amato, R J Barohn, C E Jackson, et al.
Neurology
|
December 1, 1996
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation
E J Pappert, C G Goetz, F Niederman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
The stability of carbidopa in solution
E J Pappert, J W Lipton, C G Goetz, et al.
Neurology
|
January 28, 1999
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists
E J Pappert, C G Goetz, T Q Vu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Neurology
|
October 15, 2003
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome
E J Pappert, C G Goetz, E D Louis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 1997
Progressive cognitive decline with truncal/limb ataxia and ballistic movements
K Kompoliti, E J Pappert, C G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 26, 1999
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
E J Pappert, C G Goetz, F G Niederman, et al.
Clinical Neuropharmacology
|
October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's disease
N J Diederich, C G Goetz, R Raman, et al.
European Journal of Pharmacology
|
July 3, 1998
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes
E J Pappert, C G Goetz, G T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1996
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use
E J Pappert, C Buhrfiend, J W Lipton, et al.
Neurology
|
August 1, 1994
Inclusion body myositis: treatment with intravenous immunoglobulin
A A Amato, R J Barohn, C E Jackson, et al.
Neurology
|
December 1, 1996
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation
E J Pappert, C G Goetz, F Niederman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
The stability of carbidopa in solution
E J Pappert, J W Lipton, C G Goetz, et al.
Neurology
|
January 28, 1999
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists
E J Pappert, C G Goetz, T Q Vu, et al.
Page
of 3